These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30026680)

  • 21. Roles of tau protein in health and disease.
    Guo T; Noble W; Hanger DP
    Acta Neuropathol; 2017 May; 133(5):665-704. PubMed ID: 28386764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axonal transport and mitochondrial dysfunction in Alzheimer's disease.
    Riemer J; Kins S
    Neurodegener Dis; 2013; 12(3):111-24. PubMed ID: 23037012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease.
    Eckert A; Nisbet R; Grimm A; Götz J
    Biochim Biophys Acta; 2014 Aug; 1842(8):1258-66. PubMed ID: 24051203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease.
    Jeong S
    Mol Cells; 2017 Sep; 40(9):613-620. PubMed ID: 28927263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease.
    Guerrero-Muñoz MJ; Gerson J; Castillo-Carranza DL
    Front Cell Neurosci; 2015; 9():464. PubMed ID: 26696824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability.
    Alonso AD; Cohen LS; Corbo C; Morozova V; ElIdrissi A; Phillips G; Kleiman FE
    Front Cell Neurosci; 2018; 12():338. PubMed ID: 30356756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration.
    McInnes J
    Transl Neurodegener; 2013 May; 2(1):12. PubMed ID: 23711354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer's Disease.
    Villavicencio Tejo F; Quintanilla RA
    Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brief update on different roles of tau in neurodegeneration.
    Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
    IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain capillaries in Alzheimer's disease.
    Baloyannis SJ
    Hell J Nucl Med; 2015; 18 Suppl 1():152. PubMed ID: 26665235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.
    Terwel D; Dewachter I; Van Leuven F
    Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease.
    Marcus JN; Schachter J
    J Neurogenet; 2011 Dec; 25(4):127-33. PubMed ID: 22091726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer's Disease Pathogenesis.
    Chakravorty A; Jetto CT; Manjithaya R
    Front Aging Neurosci; 2019; 11():311. PubMed ID: 31824296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tau localises within mitochondrial sub-compartments and its caspase cleavage affects ER-mitochondria interactions and cellular Ca
    Cieri D; Vicario M; Vallese F; D'Orsi B; Berto P; Grinzato A; Catoni C; De Stefani D; Rizzuto R; Brini M; Calì T
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3247-3256. PubMed ID: 30006151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Du F; Douglas JT; Yu H; Yan SS; Yan SF
    J Alzheimers Dis; 2017; 59(1):223-239. PubMed ID: 28598851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.
    Rojo LE; Fernández JA; Maccioni AA; Jimenez JM; Maccioni RB
    Arch Med Res; 2008 Jan; 39(1):1-16. PubMed ID: 18067990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease.
    Kim DK; Mook-Jung I
    BMB Rep; 2019 Dec; 52(12):679-688. PubMed ID: 31722781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.
    Venkatramani A; Panda D
    Int J Biol Macromol; 2019 Jul; 133():473-483. PubMed ID: 31004638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.